-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $100

Benzinga·02/11/2026 14:58:25
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $96 to $100.